Integrated Diagnostics Holdings plc
IDGXF · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Revenue | $1,771 | $1,771 | $1,611 | $1,611 |
| % Growth | 0% | 10% | 0% | – |
| Cost of Goods Sold | $1,027 | $1,027 | $983 | $983 |
| Gross Profit | $745 | $745 | $628 | $628 |
| % Margin | 42% | 42% | 39% | 39% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $196 | $196 | $170 | $170 |
| SG&A Expenses | $302 | $302 | $261 | $261 |
| Sales & Mktg Exp. | $97 | $97 | $75 | $75 |
| Other Operating Expenses | -$13 | -$13 | -$22 | -$22 |
| Operating Expenses | $289 | $289 | $239 | $239 |
| Operating Income | $456 | $456 | $390 | $390 |
| % Margin | 25.7% | 25.7% | 24.2% | 24.2% |
| Other Income/Exp. Net | $1 | $1 | -$14 | -$14 |
| Pre-Tax Income | $457 | $457 | $376 | $376 |
| Tax Expense | $171 | $171 | $112 | $112 |
| Net Income | $276 | $276 | $273 | $273 |
| % Margin | 15.6% | 15.6% | 17% | 17% |
| EPS | 0.47 | 0.47 | 0.47 | 0.47 |
| % Growth | 0% | 0% | 0% | – |
| EPS Diluted | 0.47 | 0.47 | 0.47 | 0.47 |
| Weighted Avg Shares Out | 582 | 582 | 587 | 587 |
| Weighted Avg Shares Out Dil | 581 | 581 | 587 | 587 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $11 | $0 | $0 |
| Interest Expense | $0 | $0 | $1 | $1 |
| Depreciation & Amortization | $80 | $80 | $77 | $77 |
| EBITDA | $536 | $536 | $468 | $468 |
| % Margin | 30.2% | 30.2% | 29.1% | 29.1% |